The best and most concise single source for state-of-the-art
diagnosis and treatment of lung cancer -newly revised,
updated, and expanded.
Lung cancer has long been the number-one cause of death from cancer
every year and the third most frequently diagnosed after breast and
prostate cancers. In 2010, about 15% of all cancer diagnoses and
30% of all cancer deaths were due to lung cancer. Needless to say,
there is a great need for more rapid advancements in diagnosis and
treatment of this devastating disease.
Here is the comprehensively revised, updated, and expanded
edition of the well-established, evidence-based reference book that
deals with the most recent advances in lung cancer prevention,
screening, diagnosis, research, and treatment for the clinician.
Edited and authored by leading authorities in the field, this
Fourth Edition of the highly regarded Lung Cancer is better
than ever -featuring nine new chapters along with seven
re-formatted ones that are nearly brand new in content and
approach. It covers Smoking Prevention and Cessation; Molecular
Profiling; Somatic Genome Alterations in Human Lung Cancers;
Management of Multi-Focal Bronchioloalveolar Carcinoma (BAC);
Primary Tracheal Tumors; Predictive Tumor Biomarkers for EGFR
Inhibitors; Non-Small Cell and Small-Cell Lung Carcinoma; and
more.
This Fourth Edition of Lung Cancer:
* Provides the very latest research in the identification of
biomarkers to predict a high risk for developing lung cancer
– vital for implementing screening, diagnosis, and prevention
strategies
* Presents the newest lung cancer staging system, as well as
updated and cutting-edge surgical and radiation therapy techniques
that make local tumor control more effective and less invasive
while sparing normal tissues
* Discusses combined modality therapy and new chemotherapeutic
agents which are yielding higher response rates and improved
survival when used in the adjuvant setting or concurrent with
highly sophisticated radiation or proton treatment
* Offers novel and emergent approaches to preventative,
diagnostic, and therapeutic modalities with an emphasis on the best
evidence available from the latest studies and clinical trials
With almost half of the revised and updated content being brand
new, Lung Cancer, Fourth Edition, is an important and vital
resource for all medical professionals and students involved in the
care and treatment of those struck with this catastrophic
illness.
เกี่ยวกับผู้แต่ง
Jack A. Roth, MD, F.A.C.S., is Professor and Bud Johnson Clinical Distinguished Chair in the Department of Thoracic and Cardiovascular Surgery, Professor of Molecular and Cellular Oncology, Director of the W.M. Keck Center of Innovative Cancer Therapies, and Chief of the Section of Thoracic Molecular Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, USA.
James D. Cox, MD, is Professor and Head of the Department of Radiation Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, USA.
Waun Ki Hong, MD, D.M.Sc. (Hon.), is the American Cancer Society Professor and Samsung Distinguished University Chair in Cancer Medicine, as well as Professor and Head of the Division of Cancer Medicine and Professor in the Department of Thoracic/Head and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, USA.
หนังสืออิเล็กทรอนิกส์เพิ่มเติมจากผู้แต่งคนเดียวกัน / บรรณาธิการ
144,197 หนังสืออิเล็กทรอนิกส์ในหมวดหมู่นี้
